Cardiff, CA, United States of America

Costas C Loullis


Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 125(Granted Patents)


Company Filing History:


Years Active: 1995-2001

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Costas C Loullis: A Pioneer in Cytokine Research

Introduction

Costas C Loullis is a notable inventor based in Cardiff, California, recognized for his significant contributions to the field of cytokine research. With a total of five patents to his name, his work primarily revolves around developing cytokine restraining agents that have potential applications in various medical fields. Loullis's innovative approach addresses the need for novel therapeutic strategies to manage cytokine activity in pathological conditions.

Latest Patents

One of Loullis's most recent patents, titled "Cytokine Restraining Agents," presents groundbreaking peptides designed to limit or control the biological activity of cytokines. The invention outlines pharmaceutical compositions that incorporate these cytokine restraining peptides, along with methods for administering the compositions to patients. Another significant patent involves "Cytokine Restraining Agents and Methods of Use in Pathologies," where Loullis describes novel peptides that effectively serve as potent cytokine restraining agents. This patent emphasizes methods for treating conditions characterized by elevated cytokine activity, such as diabetes and glomerulonephritis, while also addressing organ protection and mitigation of chemotherapy side effects.

Career Highlights

Throughout his career, Costas C Loullis has been associated with reputable companies, including Trega Biosciences, Inc. and Houghten Pharmaceuticals, Inc. His work within these organizations has been instrumental in advancing research and development related to cytokine modulation and therapeutic applications.

Collaborations

Loullis has collaborated with several distinguished colleagues during his career, including Beverly E Girten and Mark J Suto. These collaborations have contributed to the successful development and commercialization of his innovative inventions, furthering the impact of his research in the medical field.

Conclusion

Costas C Loullis continues to be a significant figure in the realm of cytokine research and innovation. His patents reflect a commitment to improving patient outcomes through novel therapeutic interventions. Loullis's work is poised to influence the treatment of various diseases, demonstrating the enduring impact of his contributions to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…